Eye drop combo aims to replace reading glasses
NCT ID NCT04675151
Summary
This study tested whether a combination of two eye drops (Nyxol and pilocarpine) could improve near vision for reading in adults aged 40-64 with presbyopia. It involved 150 participants and measured how many letters they could read on a near-vision chart after using the drops. The goal was to see if this treatment could temporarily reduce the need for reading glasses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESBYOPIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site 1
Memphis, Tennessee, 38119, United States
-
Clinical Site 10
Roswell, Georgia, 30041, United States
-
Clinical Site 11
Maitland, Florida, 32751, United States
-
Clinical Site 12
Laguna Hills, California, 92653, United States
-
Clinical Site 13
Crystal River, Florida, 34461, United States
-
Clinical Site 14
Fargo, North Dakota, 58103, United States
-
Clinical Site 15
Powell, Ohio, 43065, United States
-
Clinical Site 16
Poughkeepsie, New York, 12603, United States
-
Clinical Site 18
St Louis, Missouri, 63101, United States
-
Clinical Site 2
Athens, Ohio, 45701, United States
-
Clinical Site 3
Pittsburg, Kansas, 66762, United States
-
Clinical Site 4
Warwick, Rhode Island, 02888, United States
-
Clinical Site 5
Longwood, Florida, 32779, United States
-
Clinical Site 6
Newport Beach, California, 92663, United States
-
Clinical Site 7
Cleveland, Ohio, 44115, United States
-
Clinical Site 8
Sarasota, Florida, 34239, United States
-
Clinical Site 9
Cincinnati, Ohio, 45242, United States
Conditions
Explore the condition pages connected to this study.